If you’re dealing with depression, you’ve probably heard that a mineral could help. You’ve also probably heard a lot of hype. You want to know what’s real before you spend money or add another thing to your plate.
Magnesium is a good test case. It’s cheap, it’s in plant foods you may already eat, and it has a real trial behind it. It also has real gaps in the evidence. Let’s look at both.
Key Takeaways
- A 2017 trial of 112 adults with mild-to-moderate depression found that 248 mg of magnesium a day for six weeks lowered depression scores by about 6 points.
- Improvement showed up within two weeks. Anxiety scores dropped too.
- It was a randomized crossover trial, so every person acted as their own control. That’s a strong design.
- Participants knew when they were taking magnesium, so expectation can’t be fully ruled out.
- Other trials are mixed. One placebo-controlled trial in people with low blood magnesium found a benefit. Several small ones found little.
- People who eat more magnesium tend to have less depression, but that doesn’t prove magnesium is the reason.
- Magnesium may be worth discussing with your doctor. It is not a replacement for depression care.
What Did the 2017 Magnesium and Depression Trial Find?
Emily Tarleton, Benjamin Littenberg, and colleagues at the University of Vermont published the trial in PLOS ONE. It was titled “Role of magnesium supplementation in the treatment of depression: A randomized clinical trial.”
The design: 126 adults from primary care clinics took part. The average age was 52, and 38% were men. All had mild-to-moderate depression, based on a PHQ-9 score between 5 and 19. This was a randomized crossover trial. Each person had two six-week periods, one taking magnesium and one taking nothing. Randomization decided who went first, so half started on magnesium and half started with the no-treatment period. Roughly six in ten were also on antidepressant medication.
The dose: Four 500 mg tablets of magnesium chloride a day. That works out to 248 mg of actual (elemental) magnesium. This is a healthy dose, but it’s not a large amount.
The results: After adjusting for other factors, magnesium lowered PHQ-9 scores by a net 6.0 points compared with no treatment (95% confidence interval 4.2 to 7.9). The unadjusted figure was 4.2 points. Anxiety scores on the GAD-7 dropped by a net 4.5 points. Scores began improving within two weeks. The benefit looked similar across age, gender, starting severity, and whether people took antidepressants.
The authors point out that a drop of 5 points or more on the PHQ-9 is a meaningful change for someone in treatment. Scores also crept back up after people stopped the tablets.
Side effects: Mild. Eight people reported diarrhea, and headaches were actually less common on magnesium. When asked at the end, 61% said they’d use magnesium again, 20% said maybe, and 20% said no.
How Strong Is This Study, and Where Are Its Limits?
The crossover design is a real strength. Because every person spent six weeks on magnesium and six weeks off, each one served as their own control. That cancels out differences between people, like baseline mood, age, or lifestyle. Randomizing the order helps rule out the natural ups and downs of depression, regression to the mean (extreme scores drifting back toward average), and seasonal swings. The authors also enrolled patients over a full year to soften seasonal effects, and the dropout rate was low. In the group that started with the no-treatment period, scores improved only slightly. They dropped further once those people switched to magnesium.
Still, the control wasn’t a look-alike pill. The comparison period was no treatment, not a placebo tablet, and participants knew which period they were in. That’s why the study is called open-label. It means expectation can’t be fully separated from the mineral’s own effect. Since depression responds strongly to expectation, this matters quite a bit. The authors argue that a real drop in symptoms is useful to patients either way, and that’s a fair point for a practical question. It’s a different question from whether magnesium works through a direct biological effect.
A select group. Of 1,930 patients identified, only 126 (7%) were eligible and randomized. Those who joined were open to trying a supplement. The final group was also about 96 to 98% white.
Short and single-site. Six weeks tells us nothing about long-term results. The authors call for larger, longer trials.
No blood levels. The team did not measure blood magnesium, so we don’t know if it worked better in people who were low. The tablets were donated free by the manufacturer, Alta Health Products.
Have Other Trials Found the Same Thing?
You would have already heard a lot more about magnesium if the trials consistently showed that magnesium helped depression. But it’s a mixed bag; sometimes it does, sometimes it doesn’t. Here’s what I found.
A positive placebo-controlled trial. Afsaneh Rajizadeh and colleagues, in Nutrition, gave 60 depressed people with low blood magnesium either 500 mg of magnesium oxide (not a very bioavailable form of magnesium) or a placebo for eight weeks. Depression scores (Beck Depression Inventory-II) fell 15.65 points on magnesium and 10.40 on placebo, a significant difference. Notice how much the placebo group improved. That’s typical in depression research.
A head-to-head with a drug. Lazaro Barragán-Rodríguez and colleagues, in Magnesium Research, compared magnesium chloride (450 mg elemental) with the antidepressant imipramine in 23 older adults with type 2 diabetes and low magnesium. After 12 weeks, depression scores were similar. It’s a tiny study with no placebo, so treat it as a hint.
A null result on top of an antidepressant. Beata Ryszewska-Pokraśniewicz and colleagues, in Nutrients, added either 120 mg a day of magnesium or a placebo to fluoxetine in 37 people. They found no significant difference in depression scores at eight weeks. The dose was very low and the group was small, so this study doesn’t tell us a lot.
A diabetes and heart disease trial. Zahra Hamedifard and colleagues, in Lipids in Health and Disease, gave 60 people with type 2 diabetes and heart disease either magnesium plus zinc or a placebo for 12 weeks. Depression scores dropped 1.66 points more on the supplements. Because the two minerals were combined, we can’t credit magnesium alone.
Another null result. Sepideh Mahboobi and colleagues, in Frontiers in Nutrition, tested a probiotic plus magnesium chloride in 74 adults with obesity and low mood. Mood scores did not differ significantly from placebo after nine weeks, though a marker of inflammation (CRP) dropped.
One meta-analysis is worth knowing about. In BJPsych Open, Danny Phelan and colleagues found that magnesium looked powerful in uncontrolled studies (effect size -1.60) but weak in placebo-controlled trials (-0.21). They concluded there was little evidence so far. That gap is why a placebo-controlled replication of the Vermont trial would be valuable.
Does Eating More Magnesium Lower Depression Risk?
In a 2025 analysis in Nutrition Reviews, Zahra Hajhashemy and colleagues pooled 13 observational studies covering 63,214 adults. People with the highest magnesium intake had a 34% lower risk of depression than those with the lowest. Each extra 100 mg a day was linked to a 7% lower risk, and the benefit was clearest between about 170 and 370 mg a day.
Here’s the catch. Ten of those 13 studies were cross-sectional snapshots. They can’t tell us which came first. And in a large Spanish cohort of 15,836 university graduates followed for a median of 10 years, Miguel Martínez-González and Almudena Sánchez-Villegas found no significant link (Magnesium Research).
People who eat plenty of magnesium-rich foods usually eat differently in other ways too. They tend to eat more real foods, like more beans, greens, nuts, and whole grains. Less processed food. A lot of other nutrients correlate with higher magnesium intake in ways that matter for depression.
Why Might Magnesium Affect Mood?
Nobody knows for sure. The Vermont authors say the mechanism is unclear, but they point to a few ideas. Magnesium helps block a nerve-cell channel called the NMDA receptor. When magnesium runs low, calcium and glutamate signaling may get overactive. Low magnesium and depression are also both tied to inflammation.
These are hypotheses, not proven pathways. A 2018 meta-analysis in the Nordic Journal of Psychiatry found blood magnesium was lower in depression across 11 studies, but the finding was fragile. Removing either of two particular studies erased it.
Should You Just Try Magnesium?
Blood tests don’t settle the question. You can measure serum magnesium or red blood cell membrane magnesium, but neither reliably shows how your body is doing or whether you’d benefit from a supplement. The Vermont authors make a similar point: people can have normal blood levels and still have depleted magnesium inside their cells. The meta-analysis by Phelan and colleagues also found no clear link between blood magnesium and symptom severity. In practice, the most useful test is often a trial run.
What a trial run can look like. Many people tolerate about 200 mg of elemental magnesium in the morning and 200 mg at night, especially in a gentle form. Magnesium glycinate is a common choice because it’s easy on the stomach, and it’s the form now offered by True Wealth Health Products. Give it a few weeks, since the Vermont trial saw early changes within two weeks, and pay attention to mood, sleep, and stomach comfort.
Where the limits are. The Vermont trial used 248 mg a day, and the trials above ranged from 120 to 500 mg. In my experience, many people handle 400 mg a day without trouble, but tolerance varies. Loose stools or diarrhea are the usual sign you’ve taken too much at one time, so cut back if that happens. If you have kidney disease, take medications that interact with magnesium, or take an antidepressant, check with your doctor or pharmacist before you start.
Adults are said to need roughly 310 to 420 mg a day from all sources, depending on age and sex. Good plant sources include pumpkin seeds, flaxseed, almonds, cashews, sesame seeds, cocoa, leafy greens, beans, and whole grains. Personally, I often get more than my “requirement” from my plant-based diet, and I still sleep better when I take supplemental magnesium.
Your kidneys clear extra magnesium, which is why the Vermont trial excluded people with kidney disease. And never stop or lower an antidepressant on your own.
If you’re having thoughts of harming yourself, call or text 988 in the U.S. right away.
The Bottom Line
Magnesium has one encouraging randomized crossover trial, one positive placebo-controlled trial in people with low levels, and several small null or unclear ones. That’s enough to take it seriously, but it’s not enough to call it a proven treatment. Depression is not the lack of a single nutrient, and supplying back one nutrient can’t be expected to completely reverse such a complex disease.
A smart step is to eat more magnesium-rich plant foods, try a supervised trial of magnesium with your doctor’s okay, and treat any supplement as one piece of a bigger plan that includes sleep, movement, connection, and professional care.
Ready to see what’s going on in your own body? Start with a comprehensive metabolic lab test panel, which looks at inflammation, fasting insulin, blood sugar, and much more so you have real numbers instead of guesses. Then work with a health coach to turn those results into a plan you can actually follow. Keep in mind the panel doesn’t measure magnesium directly, and blood magnesium doesn’t tell the whole story anyway, which is why a supervised trial run is the practical way to find out. Learn about metabolic lab testing and health coaching here.
